Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1068 results

Teva and Apotex prevail in sleep drug dispute

US11-05-2023Muireann Bolger

The dispute centred on a treatment that helps people adjust their circadian rhythm | Path now clear for generic drug makers to unveil biosimilar versions of the drug.

Amgen secures five-year ban on psoriasis drug copycat

US20-04-2023Liz Hockley

Court affirms decision that two Otezla patents are not invalid | Apremilast generics set for 2028 release.

Abbvie seeks to block copycat of endometriosis drug

US04-04-2023Liz Hockley

Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January.

Amarin launches Fed Circ bid to prove Hikma generic infringed heart drug

Japan, US23-03-2023Liz Hockley

Hikma label and public statements encouraged infringement, Amarin says | Delaware District Court had dismissed claims label was ‘not skinny enough’.

Exelixis takes Cipla to court over generic cancer drug

US21-03-2023Liz Hockley

Cipla claims Cabometyx patents are invalid | Exelixis wants generic blocked until at least 2030.

Edwards Lifesciences revives Fintiv challenge

US14-03-2023Muireann Bolger

Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning.

FTC targets ‘Pharma Bro’ Martin Shkreli over start-up

US24-01-2023Muireann Bolger

Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.

Jazz Pharma’s medical cannabis unit seeks to block generic

US19-01-2023Liz Hockley

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.

Third Circuit backs pharma firm in antitrust clash

US13-12-2022Staff Writer

Years-long dispute centred on treatment for gastroesophageal reflux disease | Case invited questions concerning Noerr-Pennington doctrine and immunity | Takeda | Zydus.

Voluntary licensing opens up HIV treatment to 100 countries

Belarus, Switzerland06-12-2022Staff Writer

Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees.

Showing 1 to 10 of 1068 results